Diffuse Gastric Cancer
What's New
Last Posted: May 02, 2024
- CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.
Giovanni Corso et al. JAMA Netw Open 2024 7(4) e247862 - Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
Garcia-Pelaez José et al. The Lancet. Oncology 2022 - "I have always lived with the disease in the family": family adaptation to hereditary cancer-risk.
Silva Eliana et al. BMC primary care 2022 23(1) 93 - Hereditary Diffuse Gastric Cancer-Update Based on the Current Consort Recommendations.
Treese Christoph et al. Current oncology (Toronto, Ont.) 2022 29(4) 2454-2460 - Hereditary Diffuse Gastric Cancer (HDGC). An overview.
Taja-Chayeb L et al. Clinics and research in hepatology and gastroenterology 2021 101820 - Expanding Germline Testing to All Patients With Esophagogastric Cancers—Easy to Do, Harder to Justify
JAMA Network Open, July 12, 2021 - Frequency of CDH1 Germline Mutations in Non-Gastric Cancers.
Massari Giulia et al. Cancers 2021 13(10) - Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.
McGarragle Kaitlin M et al. Familial cancer 2020 Aug - Hereditary diffuse gastric cancer: updated clinical practice guidelines.
Blair Vanessa R et al. The Lancet. Oncology 2020 Aug 21(8) e386-e397 - Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review.
Corso Giovanni et al. Cancers 2020 Jun 12(6)
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 18, 2024
- Content source: